Tokyo, July 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062187) titled 'A systematic review of the functionality of "tiliroside" for a function to reduce body weight, BMI, and abdominal fat(visceral and subcutaneous fat) in healthy adults' on July 9.

Study Type: Others,meta-analysis etc

Primary Sponsor: Institute - Oryza Oil and Fat Chemical Co., Ltd.

Condition: Condition - The subjects were healthy adults (excluding those under 18 years old, pregnant women, and lactating women) Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The objective of this study is to investigate whether the intake of tiliroside effect function to reduce body weight, BMI, and abdominal fat(visceral and subcutaneous fat) in healthy adults, including the latest RCTs. Basic objectives2 - Efficacy

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - P-Participant: Participant The subjects were healthy adults (excluding those under 18 years old, pregnant women, and lactating women)

I-intervention: Intervention (food) characteristics Continuous intake of tiliroside, Unlimited dosage forms, period and follow-up period.

C-Comparison: Comparison Placebo (The placebo's formulation is not specified)

O-Outcome: Outcome The primary outcome: Body weight, BMI, and abdominal fat (total abdominal fat area, abdominal subcutaneous fat area, and abdominal visceral fat area) The secondary outcome: Do not set

S-Study design: Randomized parallel group controlled trials, randomized crossover trials, quasi-randomized parallel group controlled trials, quasi-randomized crossover trials, non-randomized parallel group controlled trials, non-randomized crossover trials or open trial Key exclusion criteria - The literature which does not meet PICOS, such as conference abstracts (conference proceedings) that are not original articles will be excluded.

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 07 Month 08 Day Anticipated trial start date - 2026 Year 07 Month 09 Day Last follow-up date - 2026 Year 08 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071163

Disclaimer: Curated by HT Syndication.